Cytosorbents (CTSO) Tax Provisions (2012 - 2025)
Cytosorbents' (CTSO) quarterly Tax Provisions came in at -$1.4 million in Q4 2025, up 16.91% YoY from -$1.2 million in Q4 2024, and down 251.25% on a QoQ basis from -$400000.0 in Q3 2025.
Cytosorbents (CTSO) Tax Provisions (2012 - 2025) Analysis & Trends
Cytosorbents (CTSO) has 12 years of Tax Provisions data on file, last reported at -$1.4 million in Q4 2025.
- Quarterly Tax Provisions rose 16.91% year-over-year to -$1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.5 million (down 39.58% YoY) and the FY2025 annual result came in at -$1.8 million, down 6.8% from the prior year.
- Tax Provisions eased to -$1.4 million in Q4 2025, from -$400000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of -$400000.0 in Q3 2025 to a low of -$1.7 million in Q4 2024.
- A 5-year average of -$1.0 million and a median of -$953162.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2021 — Tax Provisions soared 34.7% — and 2024, when it tumbled 107.81%.
- Tracing CTSO's Tax Provisions over 5 years: stood at -$736003.0 in 2021, then sank by 48.45% to -$1.1 million in 2022, then climbed by 25.52% to -$813739.0 in 2023, then plunged by 107.81% to -$1.7 million in 2024, then gained by 16.91% to -$1.4 million in 2025.
- The last three Tax Provisions figures came in at -$1.4 million (Q4 2025), -$400000.0 (Q3 2025), and -$1.7 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 596.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 288.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 155.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 278.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.40 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 119.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -185.98 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 72.50 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.41 Mn |
| Sep 30, 2025 | -400,000.00 |
| Dec 31, 2024 | -1.69 Mn |
| Dec 31, 2023 | -813,739.00 |
| Dec 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -736,003.00 |
| Dec 31, 2020 | -1.13 Mn |
| Dec 31, 2019 | -1.09 Mn |
| Dec 31, 2018 | -619,546.00 |
| Dec 31, 2017 | -676,739.00 |
| Dec 31, 2016 | -318,550.00 |
| Dec 31, 2015 | -324,606.00 |
| Dec 31, 2012 | -391,756.00 |